nixiFLOR by Parnell Technologies is the first therapy approved by the FDA as bioequivalent to Resflor GOLD (Merck Animal ...
A. The effectiveness of peptides varies dramatically by compound and intended use. For tanning (melanotan), peptides do work, ...
The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...
Rademikibart, a next-generation immunomodulator, was associated with long-term disease control for people with moderate to ...
Getting past the barrier surrounding the eye is a difficult but necessary part of treating retinoblastoma (RB)—a form of eye ...
The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results